Altimmune, Inc. (ALT)
2.735
+0.02
(+0.92%)
USD |
NASDAQ |
Jun 08, 16:00
2.73
0.00 (0.00%)
After-Hours: 18:37
Altimmune Total Liabilities (Quarterly) : 51.64M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Agenus, Inc. | 414.44M |
| Amgen, Inc. | 83.31B |
| Halozyme Therapeutics, Inc. | 2.453B |
| Protalix Biotherapeutics, Inc. | 35.11M |
| Humacyte, Inc. | 98.93M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 335.63M |
| Shareholders Equity (Quarterly) | 283.99M |
| Debt to Equity Ratio | 0.1262 |
| Current Ratio | 29.54 |
| Net Debt Paydown Yield | -1.70% |